McKesson's proactive approach to drug supply constraints: 3 insights

Healthcare supplier McKesson formed a Critical Care Drug Task Force to proactively manage pharmaceutical supply constraints during the pandemic, according to an Oct. 27 announcement.

What you should know:

1. The task force compares the number of COVID-19 cases on local and national levels with customer demand patterns to forecast supply needs for pharmaceutical manufacturers.

2. The strategy was developed in response to pandemic-induced purchasing increases and is intended to help hospital customers remain prepared to treat COVID-19 patients.

3. The cross-functional team will continue meeting indefinitely.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast